Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
Eur Rev Med Pharmacol Sci. 2024 Feb;28(4):1259-1271. doi: 10.26355/eurrev_202402_35447.
This study aimed to assess the hepatoprotective role of oleuropein (Olp), a phenolic compound found in olive, against carbon tetrachloride (CCl4)-induced liver damage in rats.
The research involved male albino rats, which received intraperitoneal injections of 100 mg/kg b.w. of oleuropein for 8 consecutive weeks before being subjected to carbon tetrachloride (CCl4) at a dosage of 1.0 ml/kg b.w. Changes induced by CCl4 in antioxidant and inflammatory marker levels were assessed using ELISA assay kits. Moreover, CCl4-induced liver tissue architecture alteration, fibrosis, and expression pattern of protein were evaluated by performing H&E, Sirius red, Masson trichrome, and immunohistochemistry staining.
Increased serum transaminases and massive hepatic damage were observed by this liver toxicant. The hepatic injury was further evidenced by a significant decrease in antioxidant enzyme activity [superoxide dismutase (SOD), glutathione peroxidase (GPx), Glutathione (GSH) and Total Antioxidant Capacity (T-AOC)]. The administration of CCl4 resulted in an increased inflammatory response, which was measured by C-reactive protein, interleukin-6, as well as tumor necrosis factor-alpha. Olp as a curative regimen led to significant attenuation in the inflammatory response and oxidative/nitrosative stress. This polyphenol treatment improved the hepatic tissue architecture and decreased fibrosis. In the CCl4 treatment group, the expression pattern of IL-6 protein was high, whereas expression was decreased after Olp, as evidenced by immunohistochemistry staining.
The study suggests that oleuropein treatment has the potential to reduce liver damage caused by CCl4 induction by inhibiting oxidative stress and inflammation and maintaining liver tissue architecture. This could make it a promising treatment option for liver pathogenesis.
本研究旨在评估橄榄叶中发现的酚类化合物橄榄苦苷(Olp)对大鼠四氯化碳(CCl4)诱导的肝损伤的保护作用。
本研究涉及雄性白化大鼠,它们在接受 100mg/kg b.w.的橄榄苦苷腹腔注射 8 周后,再接受 1.0ml/kg b.w.的四氯化碳(CCl4)注射。使用 ELISA 试剂盒评估 CCl4 引起的抗氧化和炎症标志物水平的变化。此外,通过进行 H&E、天狼星红、马松三色和免疫组织化学染色来评估 CCl4 诱导的肝组织结构改变、纤维化和蛋白表达模式。
这种肝毒物导致血清转氨酶升高和大量肝损伤。抗氧化酶活性(超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)、谷胱甘肽(GSH)和总抗氧化能力(T-AOC))的显著下降进一步证明了肝损伤的存在。CCl4 的给药导致炎症反应增加,这可以通过 C 反应蛋白、白细胞介素-6 和肿瘤坏死因子-α来衡量。Olp 作为一种治疗方案,可显著减轻炎症反应和氧化/硝化应激。这种多酚治疗改善了肝组织结构并减少了纤维化。在 CCl4 治疗组中,IL-6 蛋白的表达模式较高,而在用 Olp 治疗后表达减少,这一点通过免疫组织化学染色得到证实。
该研究表明,橄榄苦苷治疗具有通过抑制氧化应激和炎症以及维持肝组织结构来减少 CCl4 诱导的肝损伤的潜力。这使其成为治疗肝发病机制的有前途的治疗选择。